These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31816609)

  • 41. [Time-sparing screening method for mild cognitive impairment and early Alzheimer's disease: Self- and family reports using the TMIG index of competence].
    Akasaka H; Yonezawa H; Takahashi J; Obara S; Shibata T; Suzuki M; Ishizuka N; Sato M; Kudo M; Terayama Y; Maeda T
    Nihon Ronen Igakkai Zasshi; 2020; 57(2):182-194. PubMed ID: 32475946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study.
    Patel N; Alkhouri N; Eng K; Cikach F; Mahajan L; Yan C; Grove D; Rome ES; Lopez R; Dweik RA
    Aliment Pharmacol Ther; 2014 Sep; 40(5):498-507. PubMed ID: 25041596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multielectrode array analysis of cerebrospinal fluid in Alzheimer's disease versus mild cognitive impairment: a potential diagnostic and treatment biomarker.
    Görtz P; Siebler M; Ihl R; Henning U; Luckhaus C; Supprian T; Lange-Asschenfeldt C
    Biochem Biophys Res Commun; 2013 May; 434(2):293-7. PubMed ID: 23541573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Connected Speech Deficit as an Early Hallmark of CSF-defined Alzheimer's Disease and Correlation with Cerebral Hypoperfusion Pattern.
    Mazzon G; Ajčević M; Cattaruzza T; Menichelli A; Guerriero M; Capitanio S; Pesavento V; Dore F; Sorbi S; Manganotti P; Marini A
    Curr Alzheimer Res; 2019; 16(6):483-494. PubMed ID: 31057108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study.
    Movérare-Skrtic S; Johansson P; Mattsson N; Hansson O; Wallin A; Johansson JO; Zetterberg H; Blennow K; Svensson J
    Exp Gerontol; 2012 Feb; 47(2):179-82. PubMed ID: 22210159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
    Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of paediatric PKU breath malodour, comparing glycomacropeptide with phenylalanine free L-amino acid supplements.
    Tiele A; Daly A; Hattersley J; Pinto A; Evans S; Ashmore C; MacDonald A; Covington JA
    J Breath Res; 2019 Oct; 14(1):016001. PubMed ID: 31476741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid detection of sepsis in rats through volatile organic compounds in breath.
    Guamán AV; Carreras A; Calvo D; Agudo I; Navajas D; Pardo A; Marco S; Farré R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 881-882():76-82. PubMed ID: 22209594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach.
    Bodelier AG; Smolinska A; Baranska A; Dallinga JW; Mujagic Z; Vanhees K; van den Heuvel T; Masclee AA; Jonkers D; Pierik MJ; van Schooten FJ
    Inflamm Bowel Dis; 2015 Aug; 21(8):1776-85. PubMed ID: 26199990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.
    Khoonsari PE; Shevchenko G; Herman S; Remnestål J; Giedraitis V; Brundin R; Degerman Gunnarsson M; Kilander L; Zetterberg H; Nilsson P; Lannfelt L; Ingelsson M; Kultima K
    J Alzheimers Dis; 2019; 67(2):639-651. PubMed ID: 30614806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry.
    Purkhart R; Köhler H; Liebler-Tenorio E; Meyer M; Becher G; Kikowatz A; Reinhold P
    J Breath Res; 2011 Jun; 5(2):027103. PubMed ID: 21512209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns.
    Itoh T; Miwa T; Tsuruta A; Akamatsu T; Izu N; Shin W; Park J; Hida T; Eda T; Setoguchi Y
    Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27834896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Towards optimizing the protocol for untargeted profiling of urine volatiles via gas chromatography-ion mobility spectrometry. A pilot study.
    Novakova S; Czippelova B; Baranovicova E; Sarlinova M; Urbanova A; Hatokova Z; Dzian A; Banovcin P; Strnadel J; Novak P; Horvath G; Halasova E; Skovierova H
    J Physiol Pharmacol; 2024 Apr; 75(2):215-222. PubMed ID: 38736268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploratory Study Using Urinary Volatile Organic Compounds for the Detection of Hepatocellular Carcinoma.
    Bannaga AS; Tyagi H; Daulton E; Covington JA; Arasaradnam RP
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Near-Infrared Optical Spectroscopy In Vivo Distinguishes Subjects with Alzheimer's Disease from Age-Matched Controls.
    Greco FA; McKee AC; Kowall NW; Hanlon EB
    J Alzheimers Dis; 2021; 82(2):791-802. PubMed ID: 34092628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus.
    Chambers ST; Bhandari S; Scott-Thomas A; Syhre M
    Med Mycol; 2011 Apr; 49 Suppl 1():S54-61. PubMed ID: 20795766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.